- Poster presentation
- Open Access
Cytogenetic and interphase Fluorescence in Situ Hybridization studies in patients with multiple myeloma
© Perumal et al; licensee BioMed Central Ltd. 2014
Published: 21 January 2014
Multiple myeloma (MM) is characterized by the clonal proliferation and accumulation of malignant plasma cells in the bone marrow, monoclonal protein in the blood or urine and associated organ dysfunction. Some patients may show a slow progressive evolution from monoclonal gammopathy of undetermined significance while others may be associated with features of high clonal aggressiveness such as plasma cell leukemia or extramedullary plasmacytomas. Chromosomal abnormalities (mainly IgH translocations and trisomies) have been shown to be of prognostic significance in MM. Interphase fluorescence in situ hybridization (i-FISH), in particular, has been much more effective in identifying these trisomies/ monosomies and specific translocations.
Materials and methods
The bone marrow aspirates were processed for conventional cytogenetic and interphase FISH analyses using three probes to detect del(13)(q14.3), t(4;14)(p16.3:q32) and del(17)(p13.1). A total of 30 newly diagnosed patients were studied between May 2012 and March 2013. The affected were mostly elderly people with median age of 55 years (range: 32 to 80 years) at the time of diagnosis. There were 21 males and 9 females.
Results and conclusions
Chromosomal abnormalities were detected in only 7 patients because of the low proliferation rate of plasma cells and the non-availability of analyzable metaphases. On the other hand, i-FISH revealed an abnormality in 14 patients and a normal pattern for the selected probes in the remaining 16 patients. The most frequent abnormality was found to be 13 monosomy (complete/ partial) in 13 cases followed by t(4;14) seen in 4 patients. However these abnormalities were not recognized in the karyograms. None of the cases showed a p53 deletion. Further studies employing the complete FISH panel are required for better diagnosis and prognosis.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.